X0202 SCHEDULE 13G/A 0001756235 XXXXXXXX LIVE 3 Common Stock, par value $0.0001 per share 03/31/2026 0001946563 60 Degrees Pharmaceuticals, Inc. 83006G104 1025 Connecticut Avenue NW Suite 1000 Washington D.C X1 20036 Rule 13d-1(c) Knight Therapeutics Inc. Z4 0.00 0.00 0.00 0.00 0.00 N 0 CO (1) See item 4 below. This constitutes an exit filing for the Reporting Person. 60 Degrees Pharmaceuticals, Inc. 1025 Connecticut Avenue, NW Suite 1000, Washington D.C. 20036 Knight Therapeutics Inc. 600 - 100 boul. Alexis Nihon Montreal, QC, H4M 2P2 Canada Y As of March 31, 2026, the Reporting Person no longer beneficially owns any shares of common stock of the Issuer. Accordingly, this Amendment No. 3 to Schedule 13G is being filed as an exit filing. 0% 0 0 0 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Knight Therapeutics Inc. /s/ Samira Sakhia 05/15/2026